{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T01:04:39Z","timestamp":1793581479394,"version":"4.5.0"},"reference-count":25,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jcim-2024-0427_abs_001\">\n                    <jats:title>Background and Objectives<\/jats:title>\n                    <jats:p>Cardiovascular diseases (CVDs), including acute coronary syndrome (ACS), represent a major global health challenge. Arrhythmias such as ventricular tachycardia (VT), ventricular fibrillation (VF), atrial fibrillation (AF), premature ventricular contractions (PVCs), and premature atrial contractions (PACs) frequently complicate ACS, needing effective management strategies. Omega-3 fatty acids have shown potency in preventing sudden cardiac death by modulating arrhythmias, but their acute effects in ACS patients remain controversial. This study aimed to evaluate the impact of Omega-3 supplementation on reducing common arrhythmias among ACS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2024-0427_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A randomized clinical trial involving 74 ACS patients was conducted. Participants were randomly assigned to receive either 1 gr of Omega-3 daily or placebo (olive oil capsules) for five days. Arrhythmia frequencies (AF, PVCs, PACs, VT, VF) were monitored using daily ECGs, and statistical analyses were performed using SPSS software (version 24).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2024-0427_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over the five days, patients receiving Omega-3 showed significant reductions in the occurrence of AF (26.66\u201311.66\u202f%, p=0.015), PACs (21.66\u20133.33\u202f%, p=0.043), and PVCs (36.66\u20133.33\u202f%, p=0.021) compared to the control group. The frequency of VT and VF cases was low, with only one VT case in the Omega-3 group, which resolved without intervention after the second day.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2024-0427_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights the potential of Omega-3 fatty acids as adjunct therapy for arrhythmia management post-ACS, particularly in reducing AF, PACs, and PVCs. However, the minimal effects on VF and VT and the lack of thorough statistical analysis for these arrhythmias warrant further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jcim-2024-0427","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T23:10:28Z","timestamp":1736464228000},"page":"173-180","source":"Crossref","is-referenced-by-count":1,"title":["The impact of Omega-3 supplementation on arrhythmia reduction in acute coronary syndrome patients: a randomized clinical trial"],"prefix":"10.1515","volume":"22","author":[{"given":"Roholla","family":"Hemmati","sequence":"first","affiliation":[{"name":"Department of Cardiology, School of Medicine , Ilam University of Medical Sciences , Ilam , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8350-6207","authenticated-orcid":false,"given":"Dorsa","family":"Bahrami Zanjanbar","sequence":"additional","affiliation":[{"name":"Pharmaceutical Science Research Center, Tehran Medical Sciences , Islamic Azad University , Tehran , Iran"},{"name":"GI Pharmacology Interest Group (GPIG) , Universal Scientific Education and Research Network (USERN) , Tehran , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Iman","family":"Shishesaz","sequence":"additional","affiliation":[{"name":"Medical Research Committee , Iran University of Medical Sciences , Tehran , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Soleimani","sequence":"additional","affiliation":[{"name":"Mostafa Khomeini Cardiovascular and Research Hospital , Ilam University of Medical Sciences , Ilam , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Yari","sequence":"additional","affiliation":[{"name":"Mostafa Khomeini Cardiovascular and Research Hospital , Ilam University of Medical Sciences , Ilam , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"2025121209061513708_j_jcim-2024-0427_ref_001","unstructured":"World Health Organization (WHO). WHO reveals leading causes of death and disability worldwide. World Health Organization; 2021. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"2025121209061513708_j_jcim-2024-0427_ref_002","doi-asserted-by":"crossref","unstructured":"Gaziano, TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation 2005;112:3547\u201353. https:\/\/doi.org\/10.1161\/circulationaha.105.591792.","DOI":"10.1161\/CIRCULATIONAHA.105.591792"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_003","doi-asserted-by":"crossref","unstructured":"Mc Namara, K, Alzubaidi, H, Jackson, JK. Cardiovascular disease as a leading cause of death: how are pharmacists getting involved? Integr pharm Res Pract 2019:1\u201311, https:\/\/doi.org\/10.2147\/IPRP.S133088.","DOI":"10.2147\/IPRP.S133088"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_004","unstructured":"Simons, M, Alpert, J, Cannon, C. Acute coronary syndrome: terminology and classification. Waltham, MA: UpToDate Inc; 2020."},{"key":"2025121209061513708_j_jcim-2024-0427_ref_005","doi-asserted-by":"crossref","unstructured":"Bhatt, DL, Lopes, RD, Harrington, RA. Diagnosis and treatment of acute coronary syndromes: a review. JAMA 2022;327:662\u201375. https:\/\/doi.org\/10.1001\/jama.2022.0358.","DOI":"10.1001\/jama.2022.0358"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_006","doi-asserted-by":"crossref","unstructured":"Thomas, D, Jex, N, Thornley, A. Ventricular arrhythmias in acute coronary syndromes\u2013mechanisms and management. Contin Cardiol Educ 2017;3:22\u20139. https:\/\/doi.org\/10.1002\/cce2.51.","DOI":"10.1002\/cce2.51"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_007","doi-asserted-by":"crossref","unstructured":"Piccini, JP, White, JA, Mehta, RH, Lokhnygina, Y, Al-Khatib, SM, Tricoci, P, et al.. Sustained ventricular tachycardia and ventricular fibrillation complicating non\u2013ST-segment\u2013elevation acute coronary syndromes. Circulation 2012;126:41\u20139. https:\/\/doi.org\/10.1161\/circulationaha.111.071860.","DOI":"10.1161\/CIRCULATIONAHA.111.071860"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_008","unstructured":"Rubenstein, JC, Cinquegrani, MP, Wright, J. Atrial fibrillation in acute coronary syndrome. J Atr Fibrillation 2012;5. https:\/\/doi.org\/10.4022\/jafib.551."},{"key":"2025121209061513708_j_jcim-2024-0427_ref_009","doi-asserted-by":"crossref","unstructured":"Whang, W, Peacock, J, Soto, AV, Borda, T, Bhatt, AB, Richardson, SI, et al.. Relationship between premature ventricular complexes and depressive symptoms in non-ST-elevation acute coronary syndrome. Eur Heart J: Acute Cardiovasc Care 2013;2:61\u20137. https:\/\/doi.org\/10.1177\/2048872613476101.","DOI":"10.1177\/2048872613476101"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_010","doi-asserted-by":"crossref","unstructured":"Liu, HY, Wu, JY, Chung, CP, Lee, IH, Lin, CJ, Lin, CJ, et al.. Premature atrial contractions and their association with stroke features and outcome. J Stroke Cerebrovasc Dis 2020;29. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105118.","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105118"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_011","doi-asserted-by":"crossref","unstructured":"Crea, F, Libby, P. Acute coronary syndromes: the way forward from mechanisms to precision treatment. Circulation 2017;136:1155\u201366. https:\/\/doi.org\/10.1161\/circulationaha.117.029870.","DOI":"10.1161\/CIRCULATIONAHA.117.029870"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_012","doi-asserted-by":"crossref","unstructured":"Ebbesson, SO, Devereux, RB, Cole, S, Ebbesson, LO, Fabsitz, RR, Haack, K, et al.. Heart rate is associated with red blood cell fatty acid concentration: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. Am Heart J 2010;159:1020\u20135. https:\/\/doi.org\/10.1016\/j.ahj.2010.03.001.","DOI":"10.1016\/j.ahj.2010.03.001"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_013","doi-asserted-by":"crossref","unstructured":"He, K. Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease\u2013eat fish or take fish oil supplement? Prog Cardiovasc Dis 2009;52:95\u2013114. https:\/\/doi.org\/10.1016\/j.pcad.2009.06.003.","DOI":"10.1016\/j.pcad.2009.06.003"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_014","doi-asserted-by":"crossref","unstructured":"Smith, PJ, Blumenthal, JA, Babyak, MA, Georgiades, A, Sherwood, A, Sketch, MHJr, et al.. Association between n-3 fatty acid consumption and ventricular ectopy after myocardial infarction. Am J Clin Nutr 2009;89:1315\u201320. https:\/\/doi.org\/10.3945\/ajcn.2008.26829.","DOI":"10.3945\/ajcn.2008.26829"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_015","doi-asserted-by":"crossref","unstructured":"Harris, WS, von Schacky, C. Omega-3 fatty acids, acute coronary syndrome, and sudden death. Curr Cardiovasc Risk Rep 2008;2:161\u20136. https:\/\/doi.org\/10.1007\/s12170-008-0029-9.","DOI":"10.1007\/s12170-008-0029-9"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_016","doi-asserted-by":"crossref","unstructured":"Cheng, JW, Santoni, F. Omega-3 fatty acid: a role in the management of cardiac arrhythmias? J Alternative Compl Med 2008;14:965\u201374. https:\/\/doi.org\/10.1089\/acm.2007.0765.","DOI":"10.1089\/acm.2007.0765"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_017","doi-asserted-by":"crossref","unstructured":"Wang, C, Harris, WS, Chung, M, Lichtenstein, AH, Balk, EM, Kupelnick, B, et al.. n\u22123 Fatty acids from fish or fish-oil supplements, but not \u03b1-linolenic acid, benefit cardiovascular disease outcomes in primary-and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006;84:5\u201317. https:\/\/doi.org\/10.1093\/ajcn\/84.1.5.","DOI":"10.1093\/ajcn\/84.1.5"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_018","doi-asserted-by":"crossref","unstructured":"Mozaffarian, D, Rimm, EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006;296:1885\u201399. https:\/\/doi.org\/10.1001\/jama.296.15.1885.","DOI":"10.1001\/jama.296.15.1885"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_019","doi-asserted-by":"crossref","unstructured":"Wu, JH, Lemaitre, RN, King, IB, Song, X, Sacks, FM, Rimm, EB, et al.. Association of plasma phospholipid long-chain omega-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation 2012;125:1084\u201393. https:\/\/doi.org\/10.1161\/circulationaha.111.062653.","DOI":"10.1161\/CIRCULATIONAHA.111.062653"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_020","doi-asserted-by":"crossref","unstructured":"Von Schacky, C. Omega-3 Fatty acids: anti-arrhythmic, pro-arrhythmic, or both? Front Physiol 2012;3:20885. https:\/\/doi.org\/10.3389\/fphys.2012.00088.","DOI":"10.3389\/fphys.2012.00088"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_021","doi-asserted-by":"crossref","unstructured":"Saravanan, P, Bridgewater, B, West, AL, O\u2019Neill, SC, Calder, PC, Davidson, NC. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ: Arrhythmia Electrophysiol 2010;3:46\u201353. https:\/\/doi.org\/10.1161\/circep.109.899633.","DOI":"10.1161\/CIRCEP.109.899633"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_022","unstructured":"Nifontov, E, Shikhaliev, D, Bogachev, M, Krasichkov, A, Shliakhto, E. Antiarrhythmic activity of omega-3 polyunsaturated fatty acids in patients with stable ischemic heart disease and ventricular rhythm disturbances. Kardiologiia 2010;50:4\u20139."},{"key":"2025121209061513708_j_jcim-2024-0427_ref_023","doi-asserted-by":"crossref","unstructured":"Anand, RG, Alkadri, M, Lavie, CJ, Milani, RV. The role of fish oil in arrhythmia prevention. J Cardpulm Rehabil Prev 2008;28:92\u20138. https:\/\/doi.org\/10.1097\/01.hcr.0000314202.09676.f0.","DOI":"10.1097\/01.HCR.0000314202.09676.f0"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_024","doi-asserted-by":"crossref","unstructured":"Buchhorn, R, Baumann, C, Willaschek, C. Alleviation of arrhythmia burden in children with frequent idiopathic premature ventricular contractions by omega-3-fatty acid supplementation. Int J Cardiol 2019;291:52\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2019.05.054.","DOI":"10.1016\/j.ijcard.2019.05.054"},{"key":"2025121209061513708_j_jcim-2024-0427_ref_025","doi-asserted-by":"crossref","unstructured":"Oner, T, Ozdemir, R, Doks\u00f6z, O, Genc, DB, Guven, B, Demirpence, S, et al.. Cardiac function in children with premature ventricular contractions: the effect of omega-3 polyunsaturated fatty acid supplementation. Cardiol Young 2018;28:949\u201354. https:\/\/doi.org\/10.1017\/s1047951118000574.","DOI":"10.1017\/S1047951118000574"}],"container-title":["Journal of Complementary and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2024-0427\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2024-0427\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:35:57Z","timestamp":1765539357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2024-0427\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12,27]]},"published-print":{"date-parts":[[2025,3,13]]}},"alternative-id":["10.1515\/jcim-2024-0427"],"URL":"https:\/\/doi.org\/10.1515\/jcim-2024-0427","relation":{},"ISSN":["1553-3840"],"issn-type":[{"value":"1553-3840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]}}}